NL-OMON26621Not yet recruitingNot Applicable
Reducing bilirubin induced neurological dysfunction in preterm infants: additional use of the bilirubin:albumin ratio in the treatment of hyperbilirubinemia.
eonatology, Beatrix Children's Hospital, UMC Groningen0 sites614 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 614
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Preterm infants born at gestational age less than 32 weeks;
- •2. Admittance in the first 24 hours of life to a neonatal intensive care unit care center in the Netherlands.
Exclusion Criteria
- •1. Major congenital malformations, clinical syndromes and chromosomal abnormalities that effect neurodevelopmental outcome.
Investigators
Similar Trials
Recruiting
Not Applicable
Reducing bilirubin-induced neurological dysfunction (BIND) in premature newborns, additional use of bilirubin:albumin ratio in the treatment of hyperbilirubinemianeonatal jaundicehyperbilirubinemiaNL-OMON30420niversitair Medisch Centrum Groningen614
Completed
Not Applicable
Reducing bilirubin-induced neurological dysfunction in preterm infants: additional use of the Bilirubin:Albumin Ratio in the treatment of hyperbilirubinemiaHyperbilirubinemia, bilirubin induced neurological dysfunctionNervous System DiseasesNeurological dysfunctionISRCTN74465643niversity Medical Centre Groningen (UMCG) (The Netherlands)614
Withdrawn
Not Applicable
The effects of bilirubin infusion on the innate immune response during human endotoxemia.;A parallel open label placebo controlled pilot study.Blood poisoning1000401810011954sepsisNL-OMON35603niversitair Medisch Centrum Sint Radboud22
Not yet recruiting
Unknown
to check the effect of bilirubin and albumin ratio with duration of phototherapyCTRI/2024/07/070378Datta Meghe Institute of Higher Education and Research
Active, not recruiting
Not Applicable
Hyperbilirubinemia, the favourable side effect of atazanavir? Influence of atazanavir treatment on endothelial dysfunction, vascular inflammation and heme oxygenase activity in type 2 diabetes mellitus. - Hyperbilirubinemia, the favourable side effect of atazanavir?Type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathyEUCTR2008-000771-17-NLRUNMC